Cardiomyocyte specific adipose triglyceride lipase overexpression prevents doxorubicin induced cardiac dysfunction in female mice
| Autor: | Ty T. Kim, Jason R.B. Dyck, Jeevan Nagendran, Beshay N M Zordoky, Martin E. Young, Miranda M. Y. Sung, Petra C. Kienesberger, Thomas Pulinilkunnil |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
medicine.medical_specialty
Genotype Heart Diseases medicine.medical_treatment Immunoblotting Intraperitoneal injection Mice chemistry.chemical_compound In vivo Internal medicine medicine Animals Myocytes Cardiac Doxorubicin Chromatography High Pressure Liquid Cardiotoxicity Ejection fraction Fatty acid metabolism Reverse Transcriptase Polymerase Chain Reaction business.industry Catabolism Myocardium Heart DNA Lipase Lipid Metabolism Disease Models Animal Endocrinology Gene Expression Regulation chemistry Adipose triglyceride lipase Female Cardiology and Cardiovascular Medicine business medicine.drug |
| Zdroj: | Heart. 99:1041-1047 |
| ISSN: | 1468-201X 1355-6037 |
| Popis: | Anthracyclines such as doxorubicin are an effective class of antineoplastic agents. Despite its efficacy in the treatment of a variety of cancers, the clinical use of doxorubicin is limited by cardiac side effects. While it has been suggested that doxorubicin alters myocardial fatty acid metabolism, it is poorly understood whether this is the case and whether variations in myocardial triacylglycerol (TAG) metabolism contribute to doxorubicin induced cardiotoxicity. Since TAG catabolism in the heart is controlled by adipose triglyceride lipase (ATGL), this study examined the influence of doxorubicin on cardiac energy metabolism and TAG values as well as the consequence of forced expression of ATGL in the setting of doxorubicin induced cardiotoxicity.Wild type (WT) mice and mice with cardiomyocyte specific ATGL overexpression were divided into two groups per genotype that received a weekly intraperitoneal injection of saline or doxorubicin for 4 weeks.Four weeks of doxorubicin administration significantly impaired in vivo systolic function (11% reduction in ejection fraction, p0.05), which was associated with increased lung wet to dry weight ratios. Furthermore, doxorubicin induced cardiac dysfunction was independent of changes in glucose and fatty acid oxidation in WT hearts. However, doxorubicin administration significantly reduced myocardial TAG content in WT mice (p0.05). Importantly, cardiomyocyte specific ATGL overexpression and the resulting decrease in cardiac TAG accumulation attenuated the decrease in ejection fraction (p0.05) and thus protected mice from doxorubicin induced cardiac dysfunction.Taken together, our data suggest that chronic reduction in myocardial TAG content by cardiomyocyte specific ATGL overexpression is able to prevent doxorubicin induced cardiac dysfunction. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|